Follow us on Twitter
twitter icon@FreshPatents


Polysaccharide patents

      

This page is updated frequently with new Polysaccharide-related patent applications.




 Anti-chondroitin-sulfate-e antibody patent thumbnailAnti-chondroitin-sulfate-e antibody
The present invention provides an antibody that can react with chondroitin sulfate e at a high specificity and that can be used for, for example, the detection, isolation, and so forth, of specific sulfated polysaccharides. The present invention relates to a novel anti-chondroitin sulfate e antibody that reacts with chondroitin sulfate e and does not react with chondroitin sulfate a, does not react with chondroitin sulfate b, and does not react with chondroitin sulfate d..
Seikagaku Corporation


 Methods for distinguishing and identifying plant varieties patent thumbnailMethods for distinguishing and identifying plant varieties
Methods are disclosed for distinguishing and identifying plants by measuring partial hydrolysis of polysaccharides on account of polysaccharide-hydrolyzing enzyme activity at pre-determined incubation times and temperatures. Methods also are disclosed for identifying the source organism of a heterologous polysaccharide-hydrolyzing enzyme in a plant by measuring partial hydrolysis of polysaccharides on account of polysaccharide-hydrolyzing enzyme activity at pre-determined incubation times and temperatures.
Syngenta Participations Ag


 Site-selective modification of polysaccharides and applications thereof patent thumbnailSite-selective modification of polysaccharides and applications thereof
The present invention relates to site-selective modification of polysaccharides at their reducing end by conjugation with a single aminoxy-regioselective addressable functionalized template (raft) peptide.. .
B. G. Negev Technologies And Applications Ltd.


 Biopolymer extraction patent thumbnailBiopolymer extraction
In a prior art reactor set up dense aggregates of microorganisms are formed, typically in or embedded in an extracellular matrix. Such may relate to granules, to sphere like entities having a higher viscosity than water, globules, a biofilm, etc.
Technische Universiteit Delft


 Chitin-glucan complex, its preparation, and uses patent thumbnailChitin-glucan complex, its preparation, and uses
A biocomposite powder comprising 20-95% (w/w) chitin-glucan complex (cgc), and up to 50% (w/w) mannose-containing polysaccharides, wherein the biocomposite powder has a bulk density of 0.5 to 1.0 g/cm3, and wherein greater than 60% (w/w) of the particles of the biocomposite powder have a size below 212 μm.. .
Pharma73, S.a.


 Purification of secreted polysaccharides from s. agalactiae patent thumbnailPurification of secreted polysaccharides from s. agalactiae
The invention relates to bacterial mutants, particularly from streptococcus agalactiae, that secrete capsular polysaccharide and methods of purifying the secreted bacterial capsular polysaccharides from culture medium. The extracted polysaccharides are useful for producing vaccines comprising the polysaccharides alone or conjugated to proteins..
Glaxosmithkline Biologicals Sa


 Cotton fibers with increased glucosamine content patent thumbnailCotton fibers with increased glucosamine content
An isolated nucleic acid molecule is provided comprising a nucleotide sequence which encodes a glutamine:fructose-6-phosphate amidotransferase from e. Coli which is particularly suitable for expression in cotton plant cells.
Bayer Cropscience Nv


 Bacteria and enzymes produced therefrom and methods of using same patent thumbnailBacteria and enzymes produced therefrom and methods of using same
A bacteria referred to here as bacillus subtilis 6a-1 is provided, compositions thereof and processes for use of the bacteria, spores, cells, extracts and enzymes. The compositions which comprise the bacteria, spores, cells, extracts and/or enzymes are capable of degrading polysaccharides.
Agri-king, Inc.


 Multivalent vlp conjugates patent thumbnailMultivalent vlp conjugates
The invention is directed to vaccines comprising capsular polysaccharides conjugated to one or more components of virus like particles (vlp), and methods for the administration of and methods for the manufacture of vaccines of the invention. Preferably vaccines of the invention generate a therapeutically effective response in an individual in need thereof to multiple strains and/or serotypes of the same or of different infectious agents.
Inventprise, Llc


 Algae-derived flexible foam, and  manufacturing the same patent thumbnailAlgae-derived flexible foam, and manufacturing the same
This document discloses algae-derived flexible foams, whether open-cell or closed-cell, with inherent antimicrobial and flame resistant properties, wherein a process of manufacturing includes the steps of: harvesting algae-biomass; sufficiently drying the algae biomass; blending the dried algae biomass with a carrier resin and various foaming ingredients; adding an algal-derived antimicrobial compound selected from various natural sulfated polysaccharides present in brown algae, red algae, and/or certain seaweeds (marine microalgae); and adding a sufficient quantity of dried algae biomass to the formulation to adequately create a fire resistant flexible foam material.. .
Bloom Holdings Llc


Polymer compositions as a binder system for lithium-ion batteries

The invention relates to a polymer composition p containing: 100 parts-by-weight of polymer 1, which polymer is at least 50 g/l water-soluble at 25° c. And 1 bar, and can be produced via radical-initiated polymerisation of more than 95 wt.
Wacker Chemie Ag

N-terminal derivatisation of proteins with polysaccharides

The present invention relates to methods for producing n-terminal derivatives of proteins in which a polysaccharide, preferably having at least terminal sialic units, and preferably consisting essentially only of sialic acid units, is reacted at the n-terminus of a protein or peptide under controlled conditions to produce an n-terminal derivative. The controlled conditions include use of acidic ph for the derivatisation step and a higher ph for purification.
Lipoxen Technologies Limited

Application of fructus schisandrae total polysaccharides in preparatoin of medicine or nutraceuticals used for treating coughing

The present invention relates to a new application of fructus schisandrae total polysaccharides in preparation of medicine or nutraceuticals for treating coughing, and more specifically to a new application of fructus schisandrae total polysaccharides in preparation of medicine or nutraceuticals for preventing and relieving coughing and eliminating airway inflammation. Experiments demonstrate that the fructus schisandrae total polysaccharides can remarkably reduce the coughing times of a guinea pig with increased cough sensitivity induced by cigarette smoke and an acute cough guinea pig induced by citric acid smoke, prolong the latent period of cough, and significantly reduce the airway inflammation of the guinea pig with increased cough susceptibility induced by cigarette smoke, so that the fructus schisandrae total polysaccharides can be used for preparing drugs for preventing cough, relieving cough and eliminating airway inflammation..
State Key Laboratory Of Respiratory Disease

A novel downstream process for purifying polysaccharides

The present invention relates to a novel process for purifying bacterial polysaccharide. It is an efficient and scalable process for removing impurities from neisseria meningitidis serogroup c (men-c) polysaccharide which is capable of being used as such in a derivatized form or linked to other molecules, for the preparation of vaccines, more particularly conjugate vaccines for n.
Msd Wellcome Trust Hilleman Laboratories Pvt. Ltd.

Cationic polysaccharides for delivery of phosphoinositides to cells for therapeutic purpose

The present invention provides a complex comprising at least one phosphoinositide and at least one positively charged modified polysaccharide, pharmaceutical compositions comprising the complex, methods for treatment of a disease, disorder or condition associated with impaired phosphoinositide-mediated signaling comprising administering the complex to an subject in need, and methods for delivery of a phosphoinositide into cells, comprising contacting the cells with the complex of the invention.. .
The National Institute For Biotechnology In The Negev Ltd.

Plant extract compositions and methods of preparation thereof

Embodiments described herein relate generally to plant extract compositions and methods to isolate cutin-derived monomers, oligomers, and mixtures thereof for application in agricultural coating formulations, and in particular, to methods of preparing plant extract compositions that include functionalized and non-functionalized fatty acids and fatty esters (as well as their oligomers and mixtures thereof), which are substantially free from accompanying plant-derived compounds (e.g., proteins, polysaccharides, phenols, lignans, aromatic acids, terpenoids, flavonoids, carotenoids, alkaloids, alcohols, alkanes, and aldehydes) and can be used in agricultural coating formulations.. .
Apeel Technology, Inc.

Aqueous agroformulation comprising suspended pesticide, cellulose ether and thickener

The present invention relates to an aqueous composition comprising a water-insoluble pesticide in form of suspended particles, a cellulose ether selected from methylhydroxyethyl cellulose or methylhydroxypropyl cellulose, and a thickener selected from inorganic clays or polysaccharides which are different from the cellulose ether. The invention furthermore relates to a process for the preparation of this composition; to a method of controlling phytopathogenic fungi and/or undesired plant growth and/or undesired insect or mite attack and/or for regulating the growth of plants, wherein the composition is allowed to act on the respective pests, their environment or the plants to be protected from the respective pest, on the soil and/or on undesired plants and/or on the crop plants and/or their environment; and furthermore to seed comprising the composition..
Basf Se

Capsular polysaccharide solubilisation and combination vaccines

Precipitated bacterial capsular polysaccharides can be efficiently re-solubilised using alcohols as solvents. The invention provides a process for purifying a bacterial capsular polysaccharide, comprising the steps of (a) precipitation of said polysaccharide, followed by (b) solubilisation of the precipitated polysaccharide using ethanol.
Glaxosmithkline Biologicals Sa

Protection of progenitor cells and regulation of their differentiation

The present invention relates to the use of polysulfated polysaccharides in combination with progenitor cells to improve the viability of the progenitor cells including improving the cryopreservation of the progenitor cells and provides novel compositions, methods and uses. The present invention also relates to the use of polysulfated polysaccharides to regulate the proliferation and differentiation of progenitor cells..
Proteobioactives Pty Ltd.

Means and methods for producing neisseria meningitidis capsular polysaccharides of low dispersity

The present invention relates to in vitro methods for producing neisseria meningitidis capsular polysaccharides which have a defined length. The present invention also relates to compositions comprising at least one capsule polymerase, at least one donor carbohydrate and at least one acceptor carbohydrate, wherein the ratio of donor carbohydrate to acceptor carbohydrate is a ratio from 10:1 to 400:1.
Medizinische Hochschule Hannover

A producing aerobic-type single cell protein using the autolysis process

A method for producing aerobic-type single cell protein using the autolysis process, comprising the following steps: precipitation and concentration, centrifugal dewatering, drying, sterilization, smashing and packaging. The materials with moisture content of 78%˜85% after centrifugal dewatering are dried after the autolysis.
Icell Sustainable (shanghai) Nutrition Co., Ltd.

Compositions, methods, and medical compositions for treatment of and maintaining the health of the liver

Compositions and methods for treatment of and maintaining the health of the liver are disclosed that include a mixture of plant extracts, wherein the plant extracts comprise at least one myristica extract, at least one astragalus extract, and at least one schizandra extract. Compositions and methods for treatment of and maintaining the health of the liver are disclosed that include a mixture of plant extracts, wherein the plant extracts comprise at least one myristica extract enriched for one or more lignans, including phenylpropanoids, dimers and polymers, at least one astragalus extract enriched for one or more polysaccharides and triterpenoids, and at least one schizandra extract enriched for one or more lignans and organic acids.
Unigen, Inc.

Aloe vera extract for personal care compositions

The invention relates to a specific fraction of aloe vera extract for enhancing tight junction in skin cells. The invention more particularly relates to use of such a fraction in skin, oral and hair care compositions.
Conopco, Inc., D/b/a Unilever

Synthesis of shorter chain polyols

Disclosed herein are methods of synthesizing shorter chain polyols. Methods of hydrolyzing polysaccharides are further disclosed.
Archer Daniels Midland Company

Method to prepare ganoderma lucidum polysaccharides possessing protective activities on fatty liver disease

The present invention provides a method to prepare polysaccharides from ganoderma lucidum. The prepared polysaccharides can reduce liver weight and liver lipid content in humans and animals.
Chang Gung Biotechnology Corp.

Bacillus sp. strain with imporived productivity of fermented soybean meal and producin fermented soybean meal using the same

The present invention relates to a bacillus amyloliquefaciens k2g strain, which is excellent in removal of anti-nutritional factors and in protease activity, and shows excellent antimicrobial activity against pathogens and reduced productivity of viscous substances, a method for producing a fermented soybean meal using the strain, a fermented soybean meal produced therefrom, and a feed composition including the same. The fermented soybean meal prepared by bacillus amyloliquefaciens k2g strain according to the present invention has few anti-nutritional factors such as trypsin inhibitors, soybean oligosaccharides, and polysaccharides, a high content of crude proteins, and high protein solubility, and also consists of small-sized peptides digestible by livestock due to low-molecularization, thereby being effectively used as a high-quality vegetable protein feed having excellent absorption rate and feed efficiency..
Cj Cheiljedang Corporation

Method for manufacturing aloe extract, and aloe extract

A major object of the present technology is to provide a technology for obtaining an aloe extract which has an excellent processability into foods and contains sufficient amounts of β-sitosterol and aloe-derived dietary fibers as functional components. The present technology provides a method for manufacturing an aloe extract containing β-sitosterol, phospholipids, and dietary fibers which involves carrying out: a homogenization step for homogenizing an aloe mesophyll solution; an enzymatic degradation step for adding a polysaccharide-degrading enzyme to the homogenized aloe mesophyll solution and degrading polysaccharides contained in the aforementioned homogenized aloe mesophyll solution; and a membrane filtration step for membrane-filtering the enzyme-degraded aloe mesophyll solution with a microfiltration membrane or an ultrafiltration membrane and recovering the retentate fraction as an aloe extract..
Morinaga Milk Industry Co., Ltd.

Sialic acid derivatives for protein derivatisation and conjugation

Derivatives are synthesized of starting materials, usually polysaccharides, having sialic acid at the reducing terminal end, in which the reducing terminal unit is transformed into an aldehyde group. Where the polysaccharide has a sialic acid unit at the non-reducing end it may be passivated, for instance by converting into hydroxyl-substituted moiety.
Lipoxen Technologies Limited

Targeted gene deletions for polysaccharide slime formers

The present invention provides improved polysaccharides (e.g., gellan and diutan) produced by mutant gene r, m or n sphingomonas strains containing at least one genetic modification that favors slime-forming polysaccharide production. Methods of making the mutant sphingomonas strains and the culture broth containing such mutant sphingomonas strains are also provided..
Cp Kelco U.s., Inc.

Depolymerisation of polysaccharides and related products

Procedure for depolymerising polysaccharides using uv-vis light irradiation catalyzed by a radical photoinitiator. The polysaccharides obtained with the procedure of the invention have a average number molecular weight comprised between 5,000 and 500,000 and when dissolved in water give solutions with high concentrations and low viscosity..
Lamberti Spa

Methods for purifying polysaccharides and pharmaceutical compositions and medical devices containing the same

Methods for removing endotoxin from naturally occurring materials, such as polysaccharides (e.g., agarose and/or carrageenan) are described herein. Polysaccharides that are substantially free of endotoxins and uses thereof are also described.

Diamine crosslinking agents, crosslinked acidic polysaccharides and medical materials

[the symbols in the formula are as described in the specification]; a crosslinked acidic polysaccharide obtained by forming crosslinks by amide bonding between the amino groups in the diamine crosslinking agent and carboxyl groups in an acidic polysaccharide; and a medical material including the crosslinked product.. .

Polysaccharides from prasinococcales

There is provided a composition comprising a polysaccharide obtainable from the microalgae, prasinococcus capsulatus and strains related to p. Capsulatus for use in the treatment of disorders of the immune system, for example in psoriasis and dermatological conditions, internal immune system disorders, in particular gut inflammatory conditions and respiratory conditions.
Glycomar Limited

Ionic aqueous compositions

Disclosed herein are ionic aqueous compositions useful as nasal passage washes to aid in the resorption of edema of the respiratory mucosa, e.g., the nasal mucosa, for the treatment of respiratory tract and/or respiratory mucosal-related conditions, including, e.g., chronic rhinosinusitis, sinusitis, allergic rhinitis and nasal polyps. The composition includes an ionic aqueous solution and algae-derived constituents, such as branched, sulfated polysaccharides having an average molecular weight greater than 4 kda and comprising l-fucose and sulfate ester groups or extracts from brown algae.
Gerolymatos International S.a.

Hyaluronic acid gel composition having durability

Provided is a cross-linked polysaccharide gel composition used in cosmetics and medicine fields, and more particularly, to a hyaluronic acid gel composition having durability capable of maintaining durability for a long time within a living body without increasing a cross-linked bond rate by including a material having functions of decomposition inhibition and antioxidation of polysaccharide in cross-linked polysaccharide gel. In addition, the composition is a hydro gel complex in which ursolic acid is contained in non-cross-linked or cross-linked polysaccharides..
New Medic Co., Ltd.

Polysaccharide derivatives and cross-metathesis processes for preparing them

Methods for the cross-metathesis of polysaccharides with one or more olefin-terminated side chains and cross-metathesized products are described. In an exemplary embodiment, a method for the synthesis of cellulose ω-carboxyesters via olefin cross-metathesis with acrylates is described.
Virginia Tech Intellectual Properties, Inc.

Method for preparing alkali metal bicarbonate particles

A method for preparing alkali metal bicarbonate particles by crystallization from an alkali metal carbonate and/or bicarbonate solution with an additive present in the solution, chosen from among sulfates, sulfonates, polysulfonates, amines, hydroysultaines, polycarboxylates, polysaccharides, polyethers and ether-phenols, alkali metal hexametaphosphate, phosphates, sulfosuccinates, amidosulfonates, amine sulfonates, preferably chosen from among polysaccharides, and such that the additive is present in the solution at a concentration of at least 1 ppm and preferably at most 200 ppm.. .
Solvay Sa

Modulation of the physical interaction between platelets and the cell surface effecting cell proliferation

The growth and/or proliferation of mammalian cells are modulated by modulating the physical interaction between platelets (thrombocytes) and the surface of the cells. Sulfated polysaccharides, preferably glycosaminoglycans, can be used as a medicament for the inhibition of the physical interaction between the cell surface and platelets in the treatment of a medical disorder associated with unwanted cell growth and/or proliferation.
Cell Receptor Gmbh

New enamel-dentin adhesives based on chemically modified natural polysaccharides

The present invention concerns the preparation of chemically modified derivatives of chitosan with acrylic groups and their use in the field of enamel-dentin adhesives. Chitosan derivatives have physical-chemical features (hydrophilicity, presence of electrical charges on the chain) which allow them to interact with the organic part of the demineralized tooth.
Universita' Degli Studi Di Trieste

Phosphonated polysaccharides and gels and process for making same

Products and processes that are related to phosphonated polysaccharide compositions, including phosphonated polysaccharide gels, having a substituent degree of substitution with a lower limit of 0.02 and an upper limit of 3, and having a weight average molecular weight with an upper limit of 5,000,000 g/mole, as well as to oil field application or fracturing fluid compositions comprising such phosphonated polysaccharide compositions.. .
Rhodia Operations

Useful polysaccharide after radiation sterilization

A purified and sterilized polysaccharide that exhibits enhanced and extended shelf life over conventionally prepared polysaccharides for biomedical applications. The polysaccharide, upon crosslinking, forms a hydrogel that functions as a protective coating or on tissue and structures in the ears, nose, throat, limbs and spinal column..
Medtronic Xomed, Inc.

Method to prepare hirsutella sinensis polysaccharides possessing protective activities on fatty liver disease

The present invention provides a method to prepare polysaccharides from hirsutella sinensis. The prepared polysaccharides can reduce liver size, weight and the number and size of liver lipid vacuoles, as well as serum triglycerides and serum aspartate aminotransferase levels in humans and animals.
Chang Gung Biotechnology Corp.

Method to prepare hirsutella sinensis polysaccharides possessing anti-obesity properties and uses thereof

The present invention provides a method to prepare polysaccharides from hirsutella sinensis. The prepared polysaccharides reduce body weight and fat accumulation in laboratory animals, and can therefore be used to prevent and treat obesity..
Chang Gung Biotechnology Corp.

Method to prepare hirsutella sinensis polysaccharides possessing insulin-sensitizing properties and applications thereof

The present invention provides a method to prepare polysaccharides from hirsutella sinensis. The prepared polysaccharides can reduce hyperglycemia and insulin resistance, and can therefore be used to prevent and treat type 2 diabetes and related conditions..
Chang Gung Biotechnology Corp.

Method to prepare ganoderma lucidum polysaccharides possessing insulin-sensitizing properties and applications thereof

The present invention provides a method to prepare polysaccharides from ganoderma lucidum. The prepared polysaccharides can reduce hyperglycemia and improve insulin sensitivity in humans and animals, and can therefore be used to prevent and treat type 2 diabetes..
Chang Gung Biotechnology Corp.

Cosmetic composition comprising at least one specific silane, at least one anionic and/or non-ionic polysaccharide and at least one water-soluble mineral salt

The invention relates to a cosmetic composition comprising: (a) one or more specific silanes, (b) one or more polysaccharides chosen from anionic or non-ionic polysaccharides, and their mixtures, (c) one or more water-soluble mineral salts. The invention also relates to a method for the cosmetic treatment of keratinous fibres, in particular human keratinous fibres, such as the hair, in which the cosmetic composition as defined above is applied to the said fibres.
L'oreal

Novel peracid-containing particle

A first aspect relates to a particle including: (a) at least one bleaching agent including an organic peroxyacid; (b) at least one component selected from: (i) saccharides and polysaccharides, and derivatives thereof; (ii) inorganic fillers selected from the group consisting of talcs, micas, zeolites, silicates, metal oxides and clays; and (iii) linear, branched and cross-linked polymers and copolymers; (c) at least one ph reducing agent; and (d) at least one chelating agent. Further aspects relate to a process for preparing the particle, a composition or a dough including the particle, and use of the particle in a cleaning composition, a dental care composition, a hair dyeing composition or decolouriser, an antimicrobial composition or a bleach composition..
Revolymer (u.k.) Limited

Produced water borate crosslinking compositions and use

A composition and method for treating a fracturing fluid comprising produced water with high levels of dissolved solids using a polymer crosslinked with a boron compound and a high ph alkylamine buffer. The composition improves the viscosity stability of the fracturing fluid at elevated bottom-hole temperatures, particularly when the fluid has high levels of calcium and magnesium.
Solvay Usa Inc.

Method to prepare ganoderma lucidum polysaccharides possessing anti-obesity properties and uses thereof

The present invention provides a method to prepare polysaccharides from ganoderma lucidum. The prepared polysaccharides reduce body weight and fat accumulation in laboratory animals, and can therefore be used to prevent and treat obesity..
Chang Gung Biotechnology Corp.

Depressants for mineral ore flotation

Depressants comprising one or more types of polysaccharides comprising one or more types of pentosan units are provided. Also disclosed are processes for enriching a desired mineral from an ore comprising the desired mineral and gangue, wherein the process comprises carrying out a flotation process in the presence of one or more collecting agents and one or more of the depressants..
Kemira Oyj





Follow us on Twitter
twitter icon@FreshPatents

###

This listing is a sample listing of patent applications related to Polysaccharide for is only meant as a recent sample of applications filed, not a comprehensive history. There may be associated servicemarks and trademarks related to these patents. Please check with patent attorney if you need further assistance or plan to use for business purposes. This patent data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Polysaccharide with additional patents listed. Browse our RSS directory or Search for other possible listings.


0.4267

file did exist - 2607

1 - 1 - 51